Elekta Closes Nucletron Purchase, Rounds Out Cancer Radiotherapy Lineup
This article was originally published in The Gray Sheet
Executive Summary
Elekta’s recently completed acquisition of Nucletron adds brachytherapy devices to its radiation oncology offerings, enabling the firm to offer “a complete range of radiotherapy technologies,” the company said.